Bronchonib 150mg Capsule

About

Bronchonib, an antifibrotic agent, is specifically designed to treat progressive fibrosing interstitial lung diseases (ILDs), such as idiopathic pulmonary fibrosis (IPF). Its mechanism of action typically involves inhibiting multiple tyrosine kinases, including platelet-derived growth factor receptor (PDGFR), fibroblast growth factor receptor (FGFR), and vascular endothelial growth factor receptor (VEGFR). By targeting these crucial pathways, the drug effectively reduces the proliferation, migration, and differentiation of fibroblasts, which are key cells involved in the pathological fibrotic process within the lungs.

This targeted action ultimately slows down the progression of lung fibrosis, helping to preserve lung function and significantly reducing the rate of decline in forced vital capacity (FVC). Bronchonib represents a vital therapeutic option for managing chronic and progressive lung conditions characterized by excessive scarring of lung tissue, aiming to improve patient outcomes and quality of life.

Uses

• Treatment of idiopathic pulmonary fibrosis (IPF).
• Management of other chronic fibrosing interstitial lung diseases.
• Slowing the rate of decline in lung function.
• Reducing disease progression in specific ILDs.

Directions For Use

Take orally as prescribed by your doctor, usually twice daily with food. Swallow the capsule whole.

Benefits

• Slows the progression of lung fibrosis.
• Preserves lung function over time.
• Reduces the rate of FVC decline.
• Offers a targeted therapy for ILDs.
• Improves quality of life for some patients.
• Available in oral capsule form.

Side Effects

• Diarrhea
• Nausea
• Vomiting
• Abdominal pain
• Decreased appetite
• Weight loss
• Liver enzyme elevation
• Headache
• Hypertension
• Rash
• Fatigue
• Gastroesophageal reflux disease (GERD)

Safety Measures

• Alcohol - Limit or avoid alcohol consumption, especially due to potential for increased risk of liver enzyme elevation and gastrointestinal side effects.
• Pregnancy - Not recommended during pregnancy due to potential for fetal harm. Use effective contraception during treatment.
• Breastfeeding - Avoid breastfeeding as the drug may be excreted in breast milk and could harm the infant.
• Liver - Contraindicated in severe hepatic impairment. Use with caution and dose adjustment in mild to moderate impairment. Monitor liver function tests regularly.
• Kidney - Use with caution in patients with severe renal impairment. No specific dose adjustment usually needed, but monitor for adverse effects.
• Lung - The medication is specifically for lung conditions; however, monitor for worsening respiratory symptoms or new adverse pulmonary events.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.